Study indicates that cancer patients gain important benefits from genome-matched treatments

[Health - Medical Xpress - latest medical and]

In 2016, The Jackson Laboratory (JAX) launched the Maine Cancer Genomics Initiative (MCGI) to bring the latest progress in cancer care to rural Maine patients. Now, after successfully expanding access to genome tumor testing and targeted cancer treatments throughout Maine, the MCGI team provides compelling evidence that genome-matched treatments can provide significant patient benefit.

Continue reading...